Techcare Corp.(TECR)


Techcare Corp.(TECR)

PowerPoint / PDF SEC Filings View Website Key Statistics Company Info Management Bios

TECR Business Summary

TechCare Corp. (TECR) is a technology company with a revolutionary platform that uses proprietary cold vaporization technology to commercialize health, wellness and beauty treatments in multi-billion dollar markets. The Company’s renowned scientists have applied years of research to combine patented cold vapor technology with natural plant based compounds to create innovative solutions for today’s consumers. Products scheduled for commercial launch in 2017 include Novokid and Shine. Novokid is the first anti-lice device for home use that eliminates lice and super lice with a simple 10 minute treatment with no combing or washing. Novokid is 100% natural, plant-based and pesticide free. Shine, a haircare product, rejuvenates hair by returning its natural health, shine, body and luster by removing residues left over from pollution, hair dye and other haircare products. Additional products slated for launch in 2018 include dermatology products and De Bug, a proprietary solution to remove bed bugs. The razor/razor-blade business model for the vaporizer and single use disposable capsules is geared to generate recurring revenues. As the innovator and IP holder, TechCare partners with major distributors in each respective market, with the partners managing sales and distribution of products.


Techcare Corp.(TECR) Trade Details

  • Last Trade: 0.51
  • Change: -0.03
  • Change in %: -5.70%
  • Open: 0.51
  • High: 1.50
  • Low: 0.10
  • Volume: 1500
Techcare Corp.(TECR)
Techcare Corp.(TECR)

News for Techcare Corp.(TECR)

  • TechCare Unveils New Novokid + Lice Treatment Product for Use in Schools, Camps and Clinics

    3 May 2017 | 12:30 pm

    TechCare Corp. (TECR), a technology company with a revolutionary platform that uses cold vapor technology for natural health and beauty treatments, today announced it has designed and developed Novokid +, an institutional grade head lice treatment product based on its original Novokid for home use. TechCare expects to commercially launch Novokid + in the first quarter of 2018. Novokid is a new paradigm in the treatment of head lice, a $1.8 billion global market.  Current over-the-counter treatments are toxic, often ineffective and expensive.
  • TechCare Files Patent Application with U.S. Patent & Trademark Office for its Platform Cold Vaporization Technology

    3 April 2017 | 12:30 pm

    TechCare Corp. (TECR), a technology company with a revolutionary platform that uses cold vapor technology for natural health and beauty treatments, today announced it has filed a patent with the U.S. Patent and Trademark Office for its invention titled, "Treating an object with a gaseous compound in an airtight space". TechCare was previously issued patents in the U.S. and Europe for other components of its proprietary cold vapor technology platform, including one for treating head lice with gaseous compounds in an airtight space. "This patent addresses a key attribute of our platform technology, which utilizes natural plant-based formulations in gas form to provide superior, safer health and beauty products.
  • TechCare Announces Letter to Shareholders From Chairman and CEO

    22 February 2017 | 1:30 pm

    In August 2016, TechCare Corp. (formerly BreedIT Corp.) completed its merger with Novomic Ltd., a private company organized under the laws of the State of Israel. In connection with the merger, the Company changed its name to TechCare Corp. and instituted a reverse split of its common stock on a 1:30 basis.

Leave A Comment or Question